AKT1 and chronic myelogenous leukemia, BCR-ABL1 positive: The nude mice xenograft model was applied to confirm whether the reduction of HNRNPH1 expression could inhibit the proliferation of CML cells through the PTPN6–PI3K/AKT pathway in vivo.